Corvus Pharmaceuticals (NASDAQ:CRVS) Rating Lowered to Strong Sell at ValuEngine

Retrieved on: 2018-02-25 12:52:30

Tags for this article:

Click the tags to see associated articles and topics

Corvus Pharmaceuticals (NASDAQ:CRVS) Rating Lowered to Strong Sell at ValuEngine. View article details on hiswai:

Excerpt

<div><b>Renaissance Technologies</b> LLC increased its holdings in Corvus Pharmaceuticals by 20.5% during the fourth quarter. <b>Renaissance Technologies</b> LLC now owns 234,200 shares of the company's stock valued at $2,426,000 after buying an additional 39,900 shares during the last quarter. Finally, Spark ...</div>

Article found on:

View Original Article